A number of studies have shown MCM2 expression to be a significant prognostic marker in other tumour types including oesophageal [41] and laryngeal squamous cell carcinoma [42] and oligodendroglioma of the brain [43]. Here, MCM2 is linked to laryngeal squamous cell carcinoma.